Literature DB >> 21326718

Combining local and regional therapeutic modalities to treat hepatic malignancies.

William S Rilling1, Eric J Hohenwalter.   

Abstract

Hepatocellular carcinoma and metastatic colon cancer have proven to be challenging problems in oncology today. Currently multiple treatment options are available for treating patients with these diseases, and for this reason, a multimodality and multidisciplinary approach is needed to optimize the effectiveness of treatment. Local ablation techniques along with intra-arterial therapy may be complementary and therefore increase survival in patients being treated for hepatocellular carcinoma and metastatic colon cancer. With proper patient selection, further improvement in treatment outcomes can be achieved when these techniques are combined with surgical resection and multidrug systemic chemotherapy. Therefore, it is imperative that interventional radiologists work closely with our colleagues in other medical and surgical specialties to provide our patients with the best possible treatment options.

Entities:  

Keywords:  Ablation; combined therapy; hepatocellular carcinoma

Year:  2006        PMID: 21326718      PMCID: PMC3036303          DOI: 10.1055/s-2006-939839

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  20 in total

1.  Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma.

Authors:  D M Harnois; J Steers; J C Andrews; J C Rubin; H C Pitot; L Burgart; R H Wiesner; G J Gores
Journal:  Liver Transpl Surg       Date:  1999-05

2.  Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.

Authors:  Mary Maluccio; Anne M Covey; Ripal Gandhi; Mithat Gonen; George I Getrajdman; Lynn A Brody; Yuman Fong; William Jarnagin; Michael D'Angelica; Leslie Blumgart; Ronald DeMatteo; Karen T Brown
Journal:  J Vasc Interv Radiol       Date:  2005-07       Impact factor: 3.464

3.  Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.

Authors:  J M Llovet; J Fuster; J Bruix
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

4.  Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study.

Authors:  M Koda; Y Murawaki; A Mitsuda; K Oyama; K Okamoto; Y Idobe; T Suou; H Kawasaki
Journal:  Cancer       Date:  2001-09-15       Impact factor: 6.860

Review 5.  Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma.

Authors:  E S Chan; P K Chow; B Tai; D Machin; K Soo
Journal:  Cochrane Database Syst Rev       Date:  2000

6.  Use of Yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma.

Authors:  Michael D Liu; Michelle B Uaje; Muthana S Al-Ghazi; Denise Fields; June Herman; Jeffrey V Kuo; Norah Milne; Thong H Nguyen; Nilam S Ramsinghani; Kenneth M Tokita; Fong Y Tsai; Duane J Vajgrt; David K Imagawa
Journal:  Am Surg       Date:  2004-11       Impact factor: 0.688

7.  Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival.

Authors:  Koichiro Yamakado; Atsuhiro Nakatsuka; Masao Akeboshi; Katsuya Shiraki; Takeshi Nakano; Kan Takeda
Journal:  Oncol Rep       Date:  2004-01       Impact factor: 3.906

8.  Salvage surgery following downstaging of unresectable hepatocellular carcinoma.

Authors:  Wan-yee Lau; Stephen K W Ho; Simon C H Yu; Eric C H Lai; Choong-tsek Liew; Thomas W T Leung
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

9.  Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization.

Authors:  Mikiya Kitamoto; Masaru Imagawa; Hiroyasu Yamada; Chiyuki Watanabe; Masaaki Sumioka; Osamu Satoh; Masaru Shimamoto; Michiyo Kodama; Shojiro Kimura; Keiko Kishimoto; Yuzo Okamoto; Yasuhiko Fukuda; Kiyohiko Dohi
Journal:  AJR Am J Roentgenol       Date:  2003-10       Impact factor: 3.959

10.  Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma.

Authors:  Koji Kamada; Mikiya Kitamoto; Hiroshi Aikata; Yoshiiku Kawakami; Hirotaka Kono; Michio Imamura; Toshio Nakanishi; Kazuaki Chayama
Journal:  Am J Surg       Date:  2002-09       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.